CACCURI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 6.236
AS - Asia 2.771
EU - Europa 2.396
SA - Sud America 631
AF - Africa 70
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.123
Nazione #
US - Stati Uniti d'America 6.124
SG - Singapore 1.012
CN - Cina 823
IT - Italia 582
BR - Brasile 538
HK - Hong Kong 408
UA - Ucraina 399
DE - Germania 291
PL - Polonia 265
FI - Finlandia 202
VN - Vietnam 166
GB - Regno Unito 150
TR - Turchia 120
RU - Federazione Russa 117
FR - Francia 94
IE - Irlanda 92
IN - India 59
CA - Canada 47
SE - Svezia 43
MX - Messico 41
AR - Argentina 40
BD - Bangladesh 37
BE - Belgio 28
ID - Indonesia 25
ZA - Sudafrica 24
CZ - Repubblica Ceca 22
AT - Austria 21
IQ - Iraq 21
JP - Giappone 21
ES - Italia 20
NL - Olanda 20
UZ - Uzbekistan 13
AU - Australia 12
EC - Ecuador 12
VE - Venezuela 12
LT - Lituania 10
MA - Marocco 10
CO - Colombia 9
PK - Pakistan 9
JO - Giordania 8
ET - Etiopia 7
KE - Kenya 7
CR - Costa Rica 6
EG - Egitto 6
EU - Europa 6
NO - Norvegia 6
AZ - Azerbaigian 5
CL - Cile 5
IR - Iran 5
KG - Kirghizistan 5
PE - Perù 5
PT - Portogallo 5
PY - Paraguay 5
UY - Uruguay 5
CH - Svizzera 4
IL - Israele 4
JM - Giamaica 4
KZ - Kazakistan 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
KR - Corea 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
MU - Mauritius 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BG - Bulgaria 2
BY - Bielorussia 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
PR - Porto Rico 2
RO - Romania 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
Totale 12.119
Città #
Fairfield 717
Ashburn 555
Woodbridge 504
Singapore 455
Hong Kong 407
Seattle 352
Houston 317
Cambridge 299
Jacksonville 288
Ann Arbor 270
Warsaw 261
Chandler 255
Wilmington 240
Dallas 225
Beijing 218
Brescia 210
New York 183
Princeton 167
Helsinki 137
Los Angeles 135
Istanbul 100
Dublin 92
Munich 78
The Dalles 73
Shanghai 66
Dearborn 62
Ho Chi Minh City 62
Nanjing 61
São Paulo 53
Redondo Beach 51
Chicago 50
San Francisco 49
Des Moines 45
Buffalo 42
Hanoi 38
Moscow 36
San Diego 35
Hebei 31
Turku 30
Nanchang 29
Changsha 28
London 28
Brussels 27
Boardman 26
Jinan 24
Milan 23
Stockholm 23
Nuremberg 22
Shenyang 22
Brooklyn 21
Brno 20
Santa Clara 20
Tianjin 20
Orem 19
Mexico City 18
Rome 18
Tokyo 18
Boston 17
Charlotte 17
Johannesburg 17
Phoenix 17
Toronto 17
Denver 16
Guangzhou 15
Jiaxing 15
Rio de Janeiro 15
Manchester 14
Montreal 14
Atlanta 13
Belo Horizonte 13
Chennai 12
Curitiba 12
Dong Ket 12
Tashkent 12
Kunming 11
Poplar 11
Romola 11
Zhengzhou 11
Amsterdam 10
Frankfurt am Main 10
Salt Lake City 10
Taizhou 10
Kocaeli 9
Ningbo 9
Porto Alegre 9
Verona 9
Baghdad 8
Falkenstein 8
Haikou 8
Kilburn 8
Lallio 8
Amman 7
Auburn Hills 7
Brasília 7
Castiglione Delle Stiviere 7
Falls Church 7
Ottawa 7
Porto 7
Redwood City 7
Vienna 7
Totale 8.126
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 324
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy 249
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 204
A cluster of invasive listeriosis in Brescia, Italy. 197
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 192
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. 188
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 185
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 177
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 175
Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. 173
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 173
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. 172
In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. 169
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. 168
The immunomodulatory molecule pidotimod induces the expression of the nod-like receptor nlrp12 and attenuates tlr-induced inflammation. 160
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition 159
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 156
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 155
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 155
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 154
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. 151
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 148
Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones 147
The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions 147
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 146
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 145
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 145
Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. 145
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 144
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 143
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 143
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 140
Extensively drug-resistant Acinetobacter baumannii isolated from intensive care units in Northern Italy: a genomic approach to characterize new sequence types. 136
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. 135
Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. 135
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 135
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness 132
HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis. 132
HIV-1 matrix protein p17 and its receptors. 131
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 131
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 130
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 127
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 126
HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS. 126
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy 125
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 124
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient 123
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells 123
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case report 121
Multicenter Evaluation of the Anyplex™ Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-resistant Isolates in Pulmonary and Extrapulmonary Specimens 120
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 120
p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation 119
Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae" 116
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine. 115
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 114
A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine 113
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 112
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants 111
Programmable Nucleic Acid Nanoswitches for the Rapid, Single-Step Detection of Antibodies in Bodily Fluids 110
A topical desiccant agent in association with ultrasonic debridement in the initial treatment of chronic periodontitis: a clinical and microbiological study 108
Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120 107
Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G 104
null 104
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 101
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 100
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study 99
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 98
HIV-1 infection, microenvironment and endothelial cell dysfunction. 97
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 95
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 93
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 90
In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma 90
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 89
Role of Q675H mutation in improving SARS-CoV-2 spike interaction with the furin binding pocket 89
The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy 89
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 85
Genomic surveillance of SARS-CoV-2 in patients presenting neurological manifestations 83
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 80
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants 79
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 79
Traceability of SARS-CoV-2 transmission through quasispecies analysis 77
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 77
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 74
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants 73
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 71
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 69
Detection of SARS-CoV-2 Alpha variant in a severely immunocompromised HIV-1-infected patient in the omicron era 67
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 65
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 64
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 63
The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier 63
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 62
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 61
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 61
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies 59
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 58
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 55
Viral proteins as emerging cancer therapeutics 55
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 50
Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5 48
Totale 12.002
Categoria #
all - tutte 62.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.056 0 0 0 0 0 132 155 238 123 192 147 69
2021/2022845 71 129 9 47 17 34 45 83 32 94 63 221
2022/2023839 121 11 28 54 77 199 4 107 142 2 52 42
2023/2024895 61 18 75 65 46 141 50 43 184 26 46 140
2024/20252.127 32 14 22 284 156 195 207 103 202 191 444 277
2025/20262.845 442 622 474 584 471 252 0 0 0 0 0 0
Totale 12.424